Magnus Financial Group LLC Repligen Corp Transaction History

Magnus Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$180.37 - $226.26 $235,202 - $295,043	-1,304 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$148.08 - $206.57 $84,257 - $117,538	-569 Reduced 30.38%	1,304 $250,000
Q3 2020 Nov 05, 2020	SELL	$122.51 - $158.27 $315,585 - $407,703	-2,576 Reduced 57.9%	1,873 $276,000
Q2 2020 Aug 11, 2020	SELL	$94.33 - $140.48 $8,489 - $12,643	-90 Reduced 1.98%	4,449 $550,000
Q1 2020 May 11, 2020	BUY	$84.96 - $109.14 $13,423 - $17,244	158 Added 3.61%	4,539 $438,000
Q4 2018 Feb 13, 2019	BUY	$48.26 - $68.88 $211,427 - $301,763	4,381 New	4,381 $231,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.98B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Magnus Financial Group LLC with notifications on news.